Uterine cancer in Jewish Israeli BRCA1/2 mutation carriers.

Yael LaitmanRachel Michaelson-CohenEinat LeviRakefet Chen-ShtoyermanOrit ReishSagi Josefsberg Ben-YehoshuaRinat Bernstein-MolhoLital Keinan-BokerOra RosengartenBarbara G SilvermanTamar PerriJacob KorachPnina MorNoa Ephrat Ben-BaruchEphrat Levy LahadEitan Friedmannull null

Published in: Cancer (2018)

Israeli BRCA1 or BRCA2 mutation carriers are at an increased risk for developing uterine cancer, especially serous papillary and sarcoma. These elevated risks of uterine cancer should be discussed with BRCA carriers.

Keyphrases

papillary thyroid
squamous cell
high grade
childhood cancer
risk assessment
young adults
climate change
clear cell